Physician profile
Ali Baloch
NPI 1669146106
$1,701.99
in general payments reported to CMS, 2019-2025
18 companies · $942 in 2025
The $942 reported for 2025 was more than what 84% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $171 · 2024: $590 · 2025: $942.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,609 · Education: $92.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,609.00 |
| Education | $92.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sobi, INC | $201.72 | 2025 | |
| Springworks Therapeutics, INC. | $183.26 | 2024-2025 | Ogsiveo |
| Beone Medicines USA, INC. | $166.17 | 2025 | Tevimbra, Brukinsa |
| Jazz Pharmaceuticals INC. | $149.38 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $143.43 | 2024-2025 | Lynparza |
| Qol Medical, LLC | $143.37 | 2023 | Sucraid |
| Incyte Corporation | $118.93 | 2025 | Jakafi |
| Adaptive Biotechnologies Corporation | $116.10 | 2024-2025 | Clonoseq |
| Lilly USA, LLC | $75.87 | 2025 | Jaypirca, Verzenio |
| Bayer Healthcare Pharmaceuticals INC. | $75.42 | 2024-2025 | |
| Beigene USA, INC. | $70.29 | 2024 | Brukinsa |
| Pfizer INC. | $61.17 | 2025 | |
| Emd Serono, INC. | $55.36 | 2024-2025 | |
| Syndax Pharmaceuticals, INC. | $33.08 | 2025 | |
| Gilead Sciences, INC. | $29.48 | 2025 | Trodelvy |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $28.17 | 2025 | Opdivo |
| Exact Sciences Corporation | $27.33 | 2023 | Cologuard Collection Kit |
| Genentech USA, INC. | $23.46 | 2025 | Itovebi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ali Baloch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.